Merkel cell carcinoma (MCC) is a rare and aggressive neuroendocrine tumor characterized with high rate of metastasis and mortality. It usually appears on head and neck as solitary red lump. We presented a unique case of collision tumor of MCC with invasive squamous cell carcinoma (SCC) that was incidentally revealed by an intraoperative consultation. A 52-year-old white man presented for wide excision of chest skin lesion after recent biopsy initially diagnosed as SCC in situ. The lesion was persistent over 20 years with recent increase in size. Physical examination revealed a 15 x 20 cm sternal exophytic crusty skin lesion with palpable adenopathies at right axillary and left periclavicular neck regions. Intraoperative frozen examination of metastatic lymph nodes revealed monotonous small basophilic tumor cells with scant cytoplasm, argued against conventional type of SCC. Initial examination of the skin excision specimen confirmed SCC in situ, which was again questioned by detecting 29 of 77 resected lymph nodes that showed neoplastic cells with MCC feature. These cells are positive for CK20, synaptophysin, and p63. An extensive skin lesion sampling was performed to reveal a collision tumor with small focus of MCC (1.3 cm) overlying invasive SCC (1.5 cm). This case presents microscopic findings of a rarely reported collision tumor within a widespread background of SCC in situ. Caution should be taken when MCC is suspected as the distinctive gross feature of MCC can be hidden by the extensive background of nodularity or ulceration of SCC. 
Merkel cell carcinoma (MCC) is a rare and aggressive neuroendocrine tumor characterized with high rate of metastasis and mortality. It usually appears on head and neck as solitary red lump. We presented a unique case of collision tumor of MCC with invasive squamous cell carcinoma (SCC) that was incidentally revealed by an intraoperative consultation. A 52-year-old white man presented for wide excision of chest skin lesion after recent biopsy initially diagnosed as SCC in situ. The lesion was persistent over 20 years with recent increase in size. Physical examination revealed a 15 x 20 cm sternal exophytic crusty skin lesion with palpable adenopathies at right axillary and left periclavicular neck regions. Intraoperative frozen examination of metastatic lymph nodes revealed monotonous small basophilic tumor cells with scant cytoplasm, argued against conventional type of SCC. Initial examination of the skin excision specimen confirmed SCC in situ, which was again questioned by detecting 29 of 77 resected lymph nodes that showed neoplastic cells with MCC feature. These cells are positive for CK20, synaptophysin, and p63. An extensive skin lesion sampling was performed to reveal a collision tumor with small focus of MCC (1.3 cm) overlying invasive SCC (1.5 cm). This case presents microscopic findings of a rarely reported collision tumor within a widespread background of SCC in situ. Caution should be taken when MCC is suspected as the distinctive gross feature of MCC can be hidden by the extensive background of nodularity or ulceration of SCC. This 65-year-old white male patient presented to the VA Medical Center in 2013 with a chief complaint of memory loss. Past medical history included hypothyroidism and depression, and diagnoses of Alzheimer disease (AD) and posterior cortical atrophy were made at ages 55 and 62 years, respectively. The patient continued to work as an HVAC technician after the diagnosis of AD but was compelled to retire secondary to progressive cognitive decline. History was negative for cerebrovascular accident, seizures, lightheadedness, balance difficulties, hallucinations, and substance abuse. The patient's mother had been diagnosed with AD. Neuropsychological evaluation revealed deterioration of short-term memory and constructional apraxia with clinical progression over the ensuing three years. MRI studies done in 2012, 2014, and 2016 were interpreted as stable and within normal limits. Sleep studies were unremarkable. Cerebrospinal fluid (CSF) glucose, IgG/ albumin index, oligoclonal bands, VDRL, anti Yo and anti-Hu antibodies and taw, 14-3-3 and prion proteins were all non-contributory. CSF total protein was borderline elevated (45 mg/dL). Non-contributory serum/ plasma assays included FT-4, TT-3, TSH, myeloperoxidase and anti-proteinase antibodies, homocysteine, vitamin B-12, ANA, C and p-ANCA, atypical p-ANCA, and HIV and RPR serologies. Thyroid microsomal, anti-thyroglobulin, and anti-TPO antibodies were, however, all strongly positive. Results/Discussion: Review of the lab and imaging data suggested to neurology that the likely diagnosis was Hashimoto encephalopathy (HE) rather than AD. This rare entity is hypothesized to be of autoimmune etiology, has a strong female predominance, and is not related to thyroid function. Age of onset is generally 45-55 years old with pleiotropic presenting complaints frequently including cognitive decline. The patient was placed on high-dose prednisone with improvement of cognition. Conclusion: Although rare the diagnosis of HE is consequential as, in contrast to AD, HE irresponsive to immunosuppressive therapy.
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A Case of Atypical Myoepithelial Predominant Benign Mixed Tumor With Prominent Myxoid Stroma of the Salivary Gland
Lubna Alattia, MD, Nestor Dela Cruz, MD; Louisiana State University Health, Shreveport, LA Background: Pleomorphic adenoma is a benign tumor characterized microscopically by the presence of epithelial and modified myoepithelial cells intermingled mainly with the chondroid, and less frequently with the myxoid stroma. The myoepithelial cells are usually positive for vimentin, glial acidic fibrillary protein (GFAP), c-kit, p63, and S100 protein.
Methods:
We present unusual morphologic and immunophenotypic characteristics for a benign mixed tumor, in a 9-year-old African American boy who presented with a painless, gradually growing left parotid mass. Results: Grossly, the lesion is a 4.6 x 3.9 x 3.2 cm solid mass that is firm, red, and irregular; also, it is entirely covered by a thin glistening capsule. Microscopic examination revealed a myoepithelial predominant benign mixed tumor with prominent myxoid stroma. The tumor is circumscribed, composed of irregular nests and cords of spindly epithelioid and plasmacytoid cells, some of which appear to have intercellular junctions. The myxoid stroma has areas of fibrosis with occasional mitosis and pyknotic cells. Invasive growth and perineural and intravascular spread are not seen. Immunohistochemistry stains show S100 is positive in 80% of the tumor cells, and the vimentin is diffusely positive; p63 is patchy positive in 5% of tumor. GFAP, p40, and c-kit are negative. The Ki67 is showing up to 6% nuclear staining. Pankeratin is positive; CK7 shows patchy staining. More specifically, muscle specific actin is 1 to 2+ diffusely positive, and smooth muscle actin is diffusely 2+ positive on myoepithelial markers cells.
Conclusion:
We present a myoepithelial predominant pleomorphic adenoma, characterized by irregular nests and spindly epithelioid cords as well as plasmacytoid cells that are negative for GFAP and c-kit. It is positive for the more specific myoepithelial markers, such as smooth muscle actin.
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Malignant Pheochromocytoma With a Rare Metastasis to Thoracic Spine
Amit Reddy, MBBS, Wayne Orr, MD, Jaswinder Kaur, MD; Varsha Manucha, University of Mississippi Medical Center, Jackson, MS
Pheochromocytoma is a rare, destructive neuroendocrine malignancy that occurs primarily in the adrenal glands and can metastasize anywhere along the sympathetic chain. The diagnosis of malignant pheochromocytoma is often problematic to analyze microscopically and thus primarily dependent on the existence of local invasion or metastasis. The incidence of malignant pheochromocytoma is approximately 10% with bone metastases being most common. However, vertebral involvement is exceedingly rare with only a few cases reported. We present a case of malignant pheochromocytoma with metastatic lesions to the thoracic spine. A 60-year-old woman presented with a constant cough in the setting of increasingly intense headaches, dizziness, nausea, and vomiting over a few weeks. A chest x-ray revealed a nodule. Laboratory work-up showed significantly elevated catecholamines in both blood and urine. Computerized tomography (CT) scan demonstrated a large right sided adrenal mass with metastatic lesions to liver, sacrum and bilateral iliac bones. A radical right adrenalectomy was performed with tumor measuring 5.9x5.6cm extending into the peri-renal fat. Focal renal capsular invasion at superior pole and lymphovascular invasion was identified. Multiple wedge resections of liver and right nephrectomy were performed. Immunohistochemistry demonstrated tumor cells positive for synaptophysin and chromogranin; S100 focally highlighted sustentacular cells. Stains for cytokeratin, calretinin and MART-1 were negative. Ki-67 was approximately 8%-10%. Findings were consistent with pheochromocytoma. Germline genetic testing revealed no mutations. Patient complained of back pain at threemonth follow-up. CT showed T11 and T12 thoracic spine lesions. Subsequent bone biopsy contained bony trabeculae with trilineage hematopoietic elements and interspersed tumor cells positive for synaptophysin and negative for leukocyte common antigen, consistent with a metastatic pheochromocytoma. She underwent radiofrequency ablation and cement augmentation to the thoracic spine lesions. The surgical, radiological, and pathological overlap of this case highlights the importance of a multidisciplinary approach to these patients.
Hemophagocytic Lymphohistiocytosis in a Patient With Acute Myeloid Leukemia Involving Liver: A Case Report
Hongzhi Xu, MD, PhD, Eric Wei, MD, PhD; Louisiana State University Health, Shreveport, LA Background: Hemophagocytic lymphohistiocytosis is a rare rapidly progressive condition of immune dysregulation characterized by a hyperinflammatory response and uncontrolled T-cell and macrophage activation. Concomitant involvement of acute myeloid leukemia (AML) and hemophagocytic lymphohistiocytosis (HLH) is even more rare and presents a challenge for clinical management. Clinical Course: We present a 76-year-old man with fatigue, shortness of breath, thrombocytopenia and leukocytosis. CT revealed splenomegaly, enlarged mediastinal lymph nodes, and PET study showed bone marrow hypermetabolic activity. Hematology work up established diagnosis of AML, concomitant HLH and tumor lysis syndrome. Considering the primary problem is AML, CHEMOTHERAPY with Cytarabine was initiated. Due to continuous increasing bilirubin, liver biopsy was performed. Later the patient developed septicemia and expired. Pathology Findings: Microscopically, it revealed extensive cholestasis, bile ductule proliferation, and ballooning degeneration. The iron stain demonstrated 4+ iron and hemosiderin depositions. Within hepatic sinusoids, there were increased immature monocytic cells in single cells or in clusters, with slightly open chromatin, irregular nuclear contours, and relatively abundant cytoplasm, which were positive for CD14, CD68, and negative for CD34, CD56, and MPO. CD3 highlighted T-cells in portal tracts and occasionally in sinusoids. In hepatic sinusoids, hemophagocytic lymphohistiocytosis was seen, with macrophages or monocytes engulfing red cells. The findings are consistent with acute myeloid leukemia with monocytic differentiation, involving hepatic sinusoids, with concurrent hemophagocytic lymphohistiocytosis.
